insights_auto
Why is MRNA down 6.97%?
Dive Deeperchevron_right
MRNA:NASDAQ
Moderna Inc
$231.35
arrow_downward
-6.97%(-17.34) 1D
$232.00
arrow_upward
+0.28% (+0.65)todayPre-market
Closed: Nov 12, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
$237.88
High
$245.37
Low
$229.69
Mkt. cap
93.61B
Avg. vol.
16.95M
Volume
17.64K
52-wk high
$280.80
52-wk low
$22.28
EPS
-$7.10
Beta
1.16
Shares outstanding
404.62M
No. of employees
5K
Open
$237.88
High
$245.37
Low
$229.69
Mkt. cap
93.61B
Avg. vol.
16.95M
Volume
17.64K
52-wk high
$280.80
52-wk low
$22.28
EPS
-$7.10
Beta
1.16
Shares outstanding
404.62M
No. of employees
5K
News stories
From web sources and news partners
News Corp
·
2 hours ago
BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.
Yahoo Finance
·
11 hours ago
Moderna Targets 2027 Cancer Therapy Launch, Raises 2026 Revenue Growth Outlook
News Corp
·
12 hours ago
Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.
TradingKey
·
14 hours ago
Moderna Inc Stock (MRNA) Moved Down by 5.50% on Nov 12: Drivers Behind the Movement
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc
CEOStéphane Bancel
Employees4.7K
FoundedSep 2010
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemodernatx.com